Directions in Oncology Pharmacy®

Saturday, November 10, 2018
Crowne Plaza Times Square Manhattan
New York, New York

Directions in Oncology Pharmacy® is a regional meeting hosted by Pharmacy Times Continuing Education™ positioned to offer education for clinical specialists, infusion staff, and specialty pharmacists. The mission of Directions in Oncology Pharmacy® is to provide practical, live education to pharmacists practicing in the oncology clinic, hospital, and specialty pharmacy settings.

Learn More HERE

Read More

Oncology Nurse Navigators: Putting the Value in Value-Based Payment Models

Lani M. Alison, BSN, MS-HCQ, PCMH CCE

Oncology nurse navigators provide the “constant” in what seem to be undulating waves of changes to workflows, the adoption of new technology, the near-weekly onslaught of new drugs, and the need to ensure every nuance of documentation is entered in discrete fields in electronic health records so the practice meets reporting requirements. Read More.





Read More

PAN New Infographic Spotlight: The Medicare Patient’s Journey—Finding Financial Assistance for Prescription Medications

When a patient is diagnosed with a serious, chronic or life-threatening illness, the costs of treatment can be daunting—especially for those living on fixed incomes. 

Our latest infographic illustrates the journey of Mary, a fictional Medicare patient who searches for financial assistance after a metastatic breast cancer diagnosis. 

At age 70, Mary lives on a fixed annual income of $26,000 that goes toward necessities like rent, food and other prescriptions. She can’t afford her cancer medication: it has an out-of-pocket cost of $5,000 per year. Learn More.

Read More

The purpose of this ASCO Position Statement is to provide a summary of issues our members have raised about the role of PBMs in oncology, to share questions that have surfaced about PBM practices and their impact on physicians and patients, to assert ASCO’s immediate position on key issues, and to highlight areas of concern the Society plans to explore more deeply as part of a focused policy effort.

Read More Here

Read More

(Excerpt from Patients today are being asked to pay a significant share of prescription costs for more-expensive specialty drugs, because of high coinsurance amounts. Many patients also face a deductible for their prescriptions.These are either a combined medical-pharmacy benefit deductible or an annual prescription drug deductible that was separate from any general annual deductible.
Copayment offset programs (also called copay cards or coupons) have traditionally covered a beneficiary’s out-of-pocket costs and/or deductible for a brand-name specialty drug.
For the 2018 benefit plan year, however, many plan sponsors are adopting a copay accumulator approach that alters the conventional scenario. The impact is significant for cancer patients needing assistance to pay for pharmaceutical therapies.
Here are 3 articles to learn more about this industry trend and a download to the NCODA CoPay Accumulator brochure to help educate your patients as they manage the financial impact of copay accumulator programs.
Read More